Dietmar Schwab
- Molecular Biology
- Ophthalmology top 1%
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Co-authors
- Jörg HuwylerSonia PoliAli TabatabaeiHolger FischerPiotr SzczęsnyJayashree SahniEverson NogocekeShamil Sadikhov
- Topics
- Retinal Diseases and Treatments (9 papers)Drug Transport and Resistance Mechanisms (6 papers)Retinal Imaging and Analysis (4 papers)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Dietmar Schwab
25 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 92
- Molecular Biology 415
- Ophthalmology 372
- Oncology 305
- Radiology, Nuclear Medicine and Imaging 290
- Endocrinology, Diabetes and Metabolism 154
Countries citing papers authored by Dietmar Schwab
This map shows the geographic impact of Dietmar Schwab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dietmar Schwab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dietmar Schwab more than expected).
Fields of papers citing papers by Dietmar Schwab
This network shows the impact of papers produced by Dietmar Schwab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dietmar Schwab. The network helps show where Dietmar Schwab may publish in the future.
Co-authorship network of co-authors of Dietmar Schwab
This figure shows the co-authorship network connecting the top 25 collaborators of Dietmar Schwab. A scholar is included among the top collaborators of Dietmar Schwab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dietmar Schwab. Dietmar Schwab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 92 | |
| 4 | 179 | |
| 5 | 12 | |
| 6 | 65 | |
| 7 | 8 | |
| 8 | What is the biologically relevant KD for VEGF binding to ranibizumab in the eye? A comparison of in-vivo and in-vitro estimates. | 3 |
| 9 | The novel bispecific monoclonal anti-VEGF/anti-Ang2 antibody RG7716 shows promise in wet age-related macular degeneration patients with suboptimal response to prior anti-VEGF monotherapy | 1 |
| 10 | 78 | |
| 11 | 33 | |
| 12 | 17 | |
| 13 | 34 | |
| 14 | 157 | |
| 15 | 10 | |
| 16 | 67 | |
| 17 | 1 | |
| 18 | 6 | |
| 19 | 176 | |
| 20 | 3 |
About Dietmar Schwab
Dietmar Schwab is a scholar working on Ophthalmology, Pharmaceutical Science and Transplantation, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (9 papers), Drug Transport and Resistance Mechanisms (6 papers) and Retinal Imaging and Analysis (4 papers). The work is most often cited by research in Ophthalmology (372 citations), Otorhinolaryngology (92 citations) and Radiology, Nuclear Medicine and Imaging (290 citations). Dietmar Schwab has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Jörg Huwyler, Sonia Poli, Ali Tabatabaei, Holger Fischer, Piotr Szczęsny, Jayashree Sahni, Everson Nogoceke, Shamil Sadikhov, Sunil Patel and Pravin U. Dugel. Their work appears in journals such as Hepatology, JNCI Journal of the National Cancer Institute and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.